(Q45869589)

17 December 2017

title

Regulated expression of the interferon-beta gene in mice (English)

1 reference

17 December 2017

author name string

Harkins RN

1

1 reference

17 December 2017

Szymanski P

2

1 reference

17 December 2017

Petry H

3

1 reference

17 December 2017

Brooks A

4

1 reference

17 December 2017

Qian HS

5

1 reference

17 December 2017

Schaefer C

6

1 reference

17 December 2017

Kretschmer PJ

7

1 reference

17 December 2017

Orme A

8

1 reference

17 December 2017

Wang P

9

1 reference

17 December 2017

Rubanyi GM

10

1 reference

17 December 2017

Hermiston TW

11

1 reference

17 December 2017

publication date

19 July 2007

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

15

1 reference

17 December 2017

issue

1

1 reference

17 December 2017

page(s)

1-11

1 reference

17 December 2017

https://api.crossref.org/works/10.1038%2FSJ.GT.3302998

1 reference

Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302998

Lessons from 10 years of interferon beta-1b (Betaferon/Betaseron) treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302998

Neutralizing antibodies reduce the efficacy of betaIFN during treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302998

Cloning and expression of murine IFN beta and a TNF antagonist for gene therapy of experimental allergic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302998

Tet repressor-based system for regulated gene expression in eukaryotic cells: principles and advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302998

Ecdysone-inducible gene expression in mammalian cells and transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302998

Dimerizer-regulated gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302998

Adenovirus-mediated regulable target gene expression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302998

Antiprogestin-controllable transgene regulation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302998

The antiprogestin-dependent GeneSwitch system for regulated gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302998

Development and validation of a robust and versatile one-plasmid regulated gene expression system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302998

Mx1 and IP-10: biomarkers to measure IFN-beta activity in mice following gene-based delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302998

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302998

Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302998

Electroporation-enhanced nonviral gene transfer for the prevention or treatment of immunological, endocrine and neoplastic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302998

Plasmid-mediated muscle-targeted gene therapy for circulating therapeutic protein replacement: a tale of the tortoise and the hare?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302998

Pharmacological properties of mifepristone: toxicology and safety in animal and human studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302998

The use of mifepristone in the treatment of neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302998

Regulation of human IP-10 gene expression in astrocytoma cells by inflammatory cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302998

Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302998

Interferon-beta induces transient systemic IP-10/CXCL10 chemokine release in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302998

Gene expression profiling of relevant biomarkers for treatment evaluation in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302998

Electrotransfer into skeletal muscle for protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302998

Reducing the immunostimulatory activity of CpG-containing plasmid DNA vectors for non-viral gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302998

Long-term transgene expression from plasmid DNA gene therapy vectors is negatively affected by CpG dinucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302998

Gene expression and immune response kinetics using electroporation-mediated DNA delivery to muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302998

The soluble murine type I interferon receptor Ifnar-2 is present in serum, is independently regulated, and has both agonistic and antagonistic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302998

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302998

7 January 2021

Gene-based delivery of IFN-beta is efficacious in a murine model of experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302998

7 January 2021

Gene-based intramuscular interferon-beta therapy for experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302998

7 January 2021

Modulation of the IL-10/IL-12 cytokine circuit by interferon-beta inhibits the development of epitope spreading and disease progression in murine autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302998

7 January 2021

CpG-depleted plasmid DNA vectors with enhanced safety and long-term gene expression in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302998

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302998

1 reference

17 December 2017

Dimensions Publication ID

1029323953

0 references

Fatcat ID

release_v5xtmhncfbhajh4fqdrsjwlrhq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/v5xtmhncfbhajh4fqdrsjwlrhq

24 November 2022

mapped directly with Wikidata item

1 reference

17 December 2017